| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851719 | American Journal of Kidney Diseases | 2008 | 9 Pages |
Abstract
Ferumoxytol is well tolerated and has a safety profile similar to placebo in anemic patients with CKD stages 1 to 5 and 5D.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Ajay MD, Tejas MD, Joachim MD, Marializa MD, Annamaria MD, Louis MD,